Abiraterone acetate: oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer

por Rehman, Yasser, Rosenberg, Jonathan E
Publicado 2012

Advanced Urothelial Carcinoma: Overcoming Treatment Resistance through Novel Treatment Approaches

por Bambury, Richard M., Rosenberg, Jonathan E.
Publicado 2013

The Cost of Enfortumab Vedotin Wastage Due to Vial Size—A Real-World Analysis

por Sarfaty, Michal, Moore, Assaf, Regazzi, Ashley M., Mitchell, Aaron P., Rosenberg, Jonathan E.
Publicado 2021

Management of Dermatologic Events Associated With the Nectin-4-directed Antibody-Drug Conjugate Enfortumab Vedotin

por Lacouture, Mario E, Patel, Anisha B, Rosenberg, Jonathan E, O’Donnell, Peter H
Publicado 2022

In Reply

por Lacouture, Mario E, Patel, Anisha B, Rosenberg, Jonathan E, O’Donnell, Peter H
Publicado 2022

Treatment Decision Making in Patients with Bladder Cancer

por Berry, Donna L., Nayak, Manan, Halpenny, Barbara, Harrington, Shannon, Loughlin, Kevin R., Chang, Peter, Rosenberg, Jonathan E., Kibel, Adam S.
Publicado 2015

“Primary” and “secondary” muscle-invasive bladder cancer is more than just a surrogate for molecular subtypes

por Pietzak, Eugene J., Al-Ahmadie, Hikmat, Walasek, Aleksandra, Bajorin, Dean F., Rosenberg, Jonathan E., Bochner, Bernard H., Solit, David B., Iyer, Gopa
Publicado 2019

Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes

por Solovyov, Alexander, Vabret, Nicolas, Arora, Kshitij S., Snyder, Alexandra, Funt, Samuel A., Bajorin, Dean F., Rosenberg, Jonathan E., Bhardwaj, Nina, Ting, David T., Greenbaum, Benjamin D.
Publicado 2018

Japanese subgroup analysis of EV‐301: An open‐label, randomized phase 3 study to evaluate enfortumab vedotin versus chemotherapy in subjects with previously treated locally advance...

por Matsubara, Nobuaki, Yonese, Junji, Kojima, Takahiro, Azuma, Haruhito, Matsumoto, Hiroaki, Powles, Thomas, Rosenberg, Jonathan E., Petrylak, Daniel P., Matsangou, Maria, Wu, Chunzhang, Campbell, Mary, Yamashiro, Mayumi
Publicado 2022

Somatic ERCC2 Mutations Are Associated with a Distinct Genomic Signature in Urothelial Tumors

por Kim, Jaegil, Mouw, Kent W, Polak, Paz, Braunstein, Lior Z, Kamburov, Atanas, Kwiatkowski, David J, Rosenberg, Jonathan E, Van Allen, Eliezer M, D'Andrea, Alan, Getz, Gad
Publicado 2016

A multifactorial model of T cell expansion and durable clinical benefit in response to a PD-L1 inhibitor

por Leiserson, Mark D. M., Syrgkanis, Vasilis, Gilson, Amy, Dudik, Miroslav, Gillett, Sharon, Chayes, Jennifer, Borgs, Christian, Bajorin, Dean F., Rosenberg, Jonathan E., Funt, Samuel, Snyder, Alexandra, Mackey, Lester
Publicado 2018

Genitourinary Medical Oncology Expert Opinion Survey Regarding Treatment Management in the COVID-19 Pandemic

por Sarfaty, Michal, Feldman, Darren R., Morris, Michael J., Motzer, Robert J., Rathkopf, Dana E., Regazzi, Ashley M., Iyer, Gopa, Voss, Martin H., Bajorin, Dean F., Rosenberg, Jonathan E.
Publicado 2021

Single Arm Phase I/II Study of Everolimus and Intravesical Gemcitabine in Patients with Primary or Secondary Carcinoma In Situ of the Bladder who failed Bacillus Calmette Guerin (N...

por Dalbagni, Guido, Benfante, Nicole, Sjoberg, Daniel D., Bochner, Bernard H., Machele Donat, S., Herr, Harry W., Mc Coy, Asia S., Fahrner, Alicia J., Retinger, Caitlyn, Rosenberg, Jonathan E., Bajorin, Dean F.
Publicado 2017

Phase I Study of Everolimus in Combination with Gemcitabine and Split-Dose Cisplatin in Advanced Urothelial Carcinoma

por Abida, Wassim, Milowsky, Matthew I., Ostrovnaya, Irina, Gerst, Scott R., Rosenberg, Jonathan E., Voss, Martin H., Apolo, Andrea B., Regazzi, Ashley M., McCoy, Asia S., Boyd, Mariel E., Bajorin, Dean F.
Publicado 2016

Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU)

por Rosenberg, Jonathan E., Park, Se Hoon, Kozlov, Vadim, Dao, Tu V., Castellano, Daniel, Li, Jian-Ri, Mukherjee, Som D., Howells, Kathryn, Dry, Hannah, Lanasa, Mark C., Stewart, Ross, Bajorin, Dean F.
Publicado 2023

DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumors

por Bambury, Richard M, Bhatt, Ami S, Riester, Markus, Pedamallu, Chandra Sekhar, Duke, Fujiko, Bellmunt, Joaquim, Stack, Edward C, Werner, Lillian, Park, Rachel, Iyer, Gopa, Loda, Massimo, Kantoff, Philip W, Michor, Franziska, Meyerson, Matthew, Rosenberg, Jonathan E
Publicado 2015

Collaborating to Move Research Forward: Proceedings of the 10th Annual Bladder Cancer Think Tank

por Kamat, Ashish M., Agarwal, Piyush, Bivalacqua, Trinity, Chisolm, Stephanie, Daneshmand, Sia, Doroshow, James H., Efstathiou, Jason A., Galsky, Matthew, Iyer, Gopa, Kassouf, Wassim, Shah, Jay, Taylor, John, Williams, Stephen B., Quale, Diane Zipursky, Rosenberg, Jonathan E.
Publicado 2016

Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma

por Bellmunt, Joaquim, Lalani, Aly-Khan A., Jacobus, Sussana, Wankowicz, Stephanie A., Polacek, Laura, Takeda, David Y., Harshman, Lauren C., Wagle, Nikhil, Moreno, Irene, Lundgren, Kevin, Bossé, Dominick, Van Allen, Eliezer M., Choueiri, Toni K., Rosenberg, Jonathan E.
Publicado 2018

Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy

por Rosenberg, Jonathan E., O’Donnell, Peter H., Balar, Arjun V., McGregor, Bradley A., Heath, Elisabeth I., Yu, Evan Y., Galsky, Matthew D., Hahn, Noah M., Gartner, Elaina M., Pinelli, Juan M., Liang, Shang-Ying, Melhem-Bertrandt, Amal, Petrylak, Daniel P.
Publicado 2019

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer

por Galsky, Matthew D, Balar, Arjun V, Black, Peter C, Campbell, Matthew T, Dykstra, Gail S, Grivas, Petros, Gupta, Shilpa, Hoimes, Christoper J, Lopez, Lidia P, Meeks, Joshua J, Plimack, Elizabeth R, Rosenberg, Jonathan E, Shore, Neal, Steinberg, Gary D, Kamat, Ashish M
Publicado 2021